Alembic Pharmaceuticals Limited — Important, 17-06-2025: Updates

Alembic Pharmaceuticals has announced a board meeting to consider the financial results for the quarter and half-year. The company has issued a corporate guarantee of USD 22 million for 4.5 years to JPMorgan Chase Bank for a term loan facility of its wholly owned US subsidiary, Alembic Pharmaceuticals Inc. This move supports the subsidiary's funding without any current outstanding guarantee liabilities on the parent company, indicating no immediate financial burden from this action.